44 results
Reset filters
Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons
Add-on treatments are the new black. They are provided (most frequently, sold) to patients undergoing in vitro fertilization on the premise that they will improve the chances of having a baby. However, the regulation of add-ons is consistently minimal, meaning that they are introduced into routine practice before they have been shown to improve the live birth rate.
Men's preconception health care in Australian general practice: GPs' knowledge, attitudes and behaviours
Potentially modifiable factors can affect male fertility and reproductive outcomes, including smoking, obesity, and older paternal age. This study surveyed GPs' knowledge about, attitudes towards, and needs for promoting fertility and preconception health to male patients.
From Stranger to Family or Something in Between: Donor Linking in an Era of Retrospective Access to Anonymous Sperm Donor Records in Victoria, Australia
Through a thematic analysis of donor-conceived adults’ and donors’ Statements of Reasons – a written document applicants were required to complete when they applied – the article explores applicants’ motivations for applying, the information they sought, and their goals with regard to contact.
Assisted reproductive technologies induce limited epigenetic variation at birth that largely resolves by adulthood
This study shows evidence for specific ART-associated variation in methylation around birth, most of which occurred independently of embryo culturing. Importantly, ART-associated epigenetic variation at birth largely resolves by adulthood with no direct evidence that it impacts on development and health.
Don’t count on freezing ovarian tissue to delay menopause or stop your biological clock
A company in the United Kingdom is offering women a procedure it says can delay menopause up to 20 years and allow women to delay having babies.
But don’t get too excited. The costs and risks are likely to outweigh the potential benefits, plus there’s so much we don’t know about the process.
Health of adults aged 22 to 35 years conceived by assisted reproductive technology
This study of the health of 193 adults conceived via ART, the largest to date globally, found no evidence of increased vascular or cardiometabolic risk, or growth or respiratory problems in the ART group compared with a non-ART group from the same source population. Follow-up observation for reproductive and later-onset adverse health effects remains important.
Oocyte donor age has a significant impact on oocyte recipients' cumulative live-birth rate: a population-based cohort study
This study shows the age of the oocyte donor is critical to the CLBR and is independent of the recipient woman's age. Recipients using oocytes from donors aged ≥35 years had a statistically significantly lower CLBR when compared with recipients using oocytes from donors aged
VARTA year in review 2019
The Victorian Assisted Reproductive Treatment Authority is the independent regulator of fertility treatment in Victoria, Australia. In 2018-19 we educated people about what they can do to improve their chance of having a baby, we regulated clinics to promote the best interests of patients and their future children, and we supported people involved in donor conception to get the information they want. Here is a snapshot of our annual report,
which includes data on treatment provided by registered clinics.
Child safety and protection - Code of conduct
This Code of Conduct applies to all employees, volunteers and contractors working at VARTA, and their compliance is required. It is particularly pertinent for VARTA’s counsellors, who are more likely to interact with children and young people in the course of information and support sessions.
This Code of Conduct makes reference to and incorporates the Code of Conduct for Victorian Public Sector Employees. VARTA is bound by that Code of Conduct and adheres to it in accordance with section 61 of the Public Administration Act 2004 (Vic).